Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| BRCA2 Protein | 5 | 2020 | 50 | 1.330 |
Why?
|
| Gene Silencing | 3 | 2020 | 154 | 0.670 |
Why?
|
| Peroxiredoxins | 1 | 2020 | 10 | 0.650 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 89 | 0.630 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1679 | 0.600 |
Why?
|
| Transcription Factors | 8 | 2012 | 722 | 0.580 |
Why?
|
| Leishmania donovani | 3 | 2005 | 18 | 0.540 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2024 | 82 | 0.460 |
Why?
|
| MicroRNAs | 2 | 2020 | 501 | 0.440 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 534 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2012 | 933 | 0.410 |
Why?
|
| RNA, Small Interfering | 4 | 2025 | 436 | 0.400 |
Why?
|
| Leishmania | 2 | 2010 | 19 | 0.320 |
Why?
|
| Leishmania major | 2 | 2010 | 23 | 0.320 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 196 | 0.300 |
Why?
|
| Macrophages | 3 | 2010 | 515 | 0.300 |
Why?
|
| Down-Regulation | 3 | 2010 | 452 | 0.290 |
Why?
|
| DNA Repair | 2 | 2011 | 196 | 0.290 |
Why?
|
| Cell Cycle | 1 | 2010 | 348 | 0.290 |
Why?
|
| Protein Transport | 3 | 2020 | 295 | 0.280 |
Why?
|
| RNA, Small Cytoplasmic | 2 | 2010 | 3 | 0.260 |
Why?
|
| Signal Recognition Particle | 2 | 2010 | 6 | 0.260 |
Why?
|
| Ribonuclease H | 1 | 2005 | 11 | 0.240 |
Why?
|
| Leishmaniasis | 1 | 2005 | 7 | 0.240 |
Why?
|
| Cell Nucleus | 3 | 2020 | 383 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 271 | 0.190 |
Why?
|
| Protein Binding | 5 | 2020 | 1076 | 0.190 |
Why?
|
| Chagas Disease | 1 | 2023 | 101 | 0.180 |
Why?
|
| Binding Sites | 3 | 2021 | 670 | 0.180 |
Why?
|
| Mitochondria | 1 | 2005 | 516 | 0.180 |
Why?
|
| Trypanosoma cruzi | 1 | 2023 | 154 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2025 | 1066 | 0.170 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 60 | 0.170 |
Why?
|
| Protein Stability | 1 | 2021 | 47 | 0.170 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 196 | 0.170 |
Why?
|
| RNA, Messenger | 5 | 2012 | 1265 | 0.170 |
Why?
|
| RNA, Untranslated | 2 | 2010 | 46 | 0.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 729 | 0.170 |
Why?
|
| Repressor Proteins | 3 | 2008 | 267 | 0.160 |
Why?
|
| Molecular Sequence Data | 6 | 2011 | 1559 | 0.160 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 448 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 4 | 2018 | 188 | 0.150 |
Why?
|
| Rad51 Recombinase | 2 | 2011 | 7 | 0.150 |
Why?
|
| Humans | 17 | 2025 | 42163 | 0.150 |
Why?
|
| Conserved Sequence | 2 | 2010 | 121 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 112 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2018 | 114 | 0.130 |
Why?
|
| Animals | 10 | 2025 | 16695 | 0.130 |
Why?
|
| Cell Line, Tumor | 8 | 2012 | 2598 | 0.130 |
Why?
|
| Amino Acid Sequence | 4 | 2008 | 1188 | 0.120 |
Why?
|
| RNA | 2 | 2011 | 266 | 0.120 |
Why?
|
| Open Reading Frames | 2 | 2005 | 81 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2010 | 44 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2020 | 990 | 0.100 |
Why?
|
| Base Sequence | 4 | 2010 | 997 | 0.100 |
Why?
|
| Alcohol Oxidoreductases | 3 | 2008 | 23 | 0.100 |
Why?
|
| Desmoplakins | 1 | 2012 | 1 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2011 | 10 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 12 | 0.090 |
Why?
|
| Mitochondrial Membranes | 2 | 2024 | 41 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 11 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 19 | 0.090 |
Why?
|
| RNA Polymerase III | 1 | 2010 | 6 | 0.090 |
Why?
|
| Macular Degeneration | 1 | 2011 | 30 | 0.080 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2010 | 18 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 44 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2010 | 55 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2010 | 60 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 16 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2011 | 40 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 228 | 0.080 |
Why?
|
| G1 Phase | 1 | 2010 | 33 | 0.080 |
Why?
|
| Codon | 1 | 2010 | 40 | 0.080 |
Why?
|
| Vertebrates | 1 | 2010 | 33 | 0.080 |
Why?
|
| U937 Cells | 2 | 2010 | 30 | 0.080 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 20 | 0.080 |
Why?
|
| Introns | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cytosol | 1 | 2010 | 98 | 0.080 |
Why?
|
| Exons | 1 | 2010 | 91 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 557 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2018 | 51 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2005 | 149 | 0.070 |
Why?
|
| Molecular Weight | 2 | 2005 | 168 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 318 | 0.070 |
Why?
|
| Cell Movement | 1 | 2012 | 640 | 0.070 |
Why?
|
| Female | 4 | 2020 | 24018 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 427 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2008 | 69 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 649 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 274 | 0.060 |
Why?
|
| Trans-Splicing | 1 | 2005 | 2 | 0.060 |
Why?
|
| Untranslated Regions | 1 | 2005 | 6 | 0.060 |
Why?
|
| Densitometry | 1 | 2005 | 14 | 0.060 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2005 | 27 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2005 | 68 | 0.060 |
Why?
|
| Genes, Protozoan | 1 | 2005 | 18 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2025 | 2111 | 0.060 |
Why?
|
| DNA, Protozoan | 1 | 2005 | 27 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 26 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 57 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2005 | 461 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2005 | 75 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2005 | 92 | 0.060 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2005 | 12 | 0.060 |
Why?
|
| Keratins | 1 | 2005 | 25 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2009 | 548 | 0.060 |
Why?
|
| Spermidine | 1 | 2005 | 34 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 195 | 0.060 |
Why?
|
| Mice | 4 | 2011 | 6490 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 108 | 0.060 |
Why?
|
| Glutathione | 1 | 2005 | 170 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 508 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 128 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 98 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2009 | 74 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 400 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 534 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 199 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 633 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 683 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 181 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 278 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 1848 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2021 | 47 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 64 | 0.030 |
Why?
|
| Cell Survival | 2 | 2011 | 934 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 279 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1617 | 0.030 |
Why?
|
| Histone Deacetylases | 2 | 2008 | 61 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2012 | 1 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 25 | 0.020 |
Why?
|
| Aptamers, Peptide | 1 | 2011 | 6 | 0.020 |
Why?
|
| Transcription Factors, TFIII | 1 | 2010 | 1 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 233 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2010 | 15 | 0.020 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2011 | 31 | 0.020 |
Why?
|
| Calpain | 1 | 2010 | 35 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 59 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 67 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 115 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 1341 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 277 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 284 | 0.020 |
Why?
|
| Claudins | 1 | 2009 | 8 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 34 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 290 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 774 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 487 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2006 | 20 | 0.020 |
Why?
|
| Dimerization | 1 | 2005 | 115 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 97 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 108 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 181 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 273 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 189 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1420 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 526 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 420 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 194 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 201 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 698 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 522 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 884 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 594 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 740 | 0.010 |
Why?
|